These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis. Agostini S; Mancuso R; Citterio LA; Caputo D; Oreni L; Nuzzi R; Pasanisi MB; Rovaris M; Clerici M Neurobiol Dis; 2024 Oct; 200():106648. PubMed ID: 39181188 [TBL] [Abstract][Full Text] [Related]
3. Differential microRNA expression in blood in multiple sclerosis. Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985 [TBL] [Abstract][Full Text] [Related]
4. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Selmaj I; Cichalewska M; Namiecinska M; Galazka G; Horzelski W; Selmaj KW; Mycko MP Ann Neurol; 2017 May; 81(5):703-717. PubMed ID: 28411393 [TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as biomarkers in progressive multiple sclerosis. Vistbakka J; Elovaara I; Lehtimäki T; Hagman S Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141 [TBL] [Abstract][Full Text] [Related]
6. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases. Sharaf-Eldin WE; Kishk NA; Gad YZ; Hassan H; Ali MAM; Zaki MS; Mohamed MR; Essawi ML J Neurol Sci; 2017 Dec; 383():188-198. PubMed ID: 29246612 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Keller A; Leidinger P; Steinmeyer F; Stähler C; Franke A; Hemmrich-Stanisak G; Kappel A; Wright I; Dörr J; Paul F; Diem R; Tocariu-Krick B; Meder B; Backes C; Meese E; Ruprecht K Mult Scler; 2014 Mar; 20(3):295-303. PubMed ID: 23836875 [TBL] [Abstract][Full Text] [Related]
8. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
9. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression. Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128 [TBL] [Abstract][Full Text] [Related]
10. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status. Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142 [TBL] [Abstract][Full Text] [Related]
11. Analysis of potential microRNA biomarkers for multiple sclerosis. Al-Temaimi R; Alshammari N; Alroughani R Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208 [TBL] [Abstract][Full Text] [Related]
12. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046 [TBL] [Abstract][Full Text] [Related]